To develop the Chinese version of Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) and examine its psychometric properties, we investigated a sample of 689 non-clinical and 309 clinical participants and found this measurement had good acceptability, internal reliability, test-retest reliability and convergent validity; it had moderate correlations with the Schwartz Outcome Scale and Symptom Check List-90, which showed an acceptable concurrent validity. Specifically, we explored the cut-off line of clinical criterion and found a g factor plus three-factor solution better than original four-domain model in Chinese context. The CORE-OM is a valid tool with referenced cut-offs to measure clinical outcomes, which can bridge the gap in routine clinical evaluation in China.